STOCK TITAN

[Form 4] Eli Lilly & Co. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Lemonade, Inc. (LMND) – Form 4 insider filing

CFO Timothy E. Bixby exercised 7,000 fully-vested employee stock options at an exercise price of $23.69, then sold the same 7,000 shares under a Rule 10b5-1 plan. The sales occurred on 18 Jul 2025 (6,000 sh. at $42.50) and 21 Jul 2025 (1,000 sh. at $42.70), generating gross proceeds of roughly $0.30 million versus an aggregate exercise cost of about $0.17 million.

After the transactions Mr. Bixby’s direct holding remains 263,393 common shares, unchanged from the level prior to the option exercises. He also retains 30,000 shares held indirectly through the Timothy E. Bixby Family Trust and 277,300 unexercised options expiring 25 Sep 2029.

The activity represents <0.02 % of LMND’s 67 million outstanding shares and appears routine portfolio diversification rather than a signal about business fundamentals. No other insiders transacted and no company cash was involved.

Lemonade, Inc. (LMND) – Comunicazione interna Form 4

Il CFO Timothy E. Bixby ha esercitato 7.000 opzioni azionarie dipendenti completamente maturate al prezzo di esercizio di 23,69 dollari, vendendo poi le stesse 7.000 azioni tramite un piano Rule 10b5-1. Le vendite sono avvenute il 18 luglio 2025 (6.000 azioni a 42,50 dollari) e il 21 luglio 2025 (1.000 azioni a 42,70 dollari), generando proventi lordi di circa 0,30 milioni di dollari contro un costo complessivo di esercizio di circa 0,17 milioni di dollari.

Dopo queste operazioni, la partecipazione diretta del sig. Bixby rimane di 263.393 azioni ordinarie, invariata rispetto al livello precedente all’esercizio delle opzioni. Detiene inoltre 30.000 azioni indirettamente tramite il Timothy E. Bixby Family Trust e 277.300 opzioni non esercitate con scadenza il 25 settembre 2029.

L’operazione rappresenta meno dello 0,02% delle 67 milioni di azioni in circolazione di LMND e sembra essere una normale diversificazione del portafoglio piuttosto che un segnale sui fondamentali aziendali. Nessun altro insider ha effettuato transazioni e non è stato coinvolto denaro aziendale.

Lemonade, Inc. (LMND) – Presentación interna Formulario 4

El CFO Timothy E. Bixby ejerció 7,000 opciones sobre acciones de empleados totalmente adquiridas a un precio de ejercicio de 23,69 dólares, para luego vender esas mismas 7,000 acciones bajo un plan Rule 10b5-1. Las ventas se realizaron el 18 de julio de 2025 (6,000 acciones a 42,50 dólares) y el 21 de julio de 2025 (1,000 acciones a 42,70 dólares), generando ingresos brutos de aproximadamente 0,30 millones de dólares frente a un costo total de ejercicio de alrededor de 0,17 millones de dólares.

Tras las transacciones, la participación directa del Sr. Bixby se mantiene en 263,393 acciones comunes, sin cambios respecto al nivel previo al ejercicio de las opciones. También conserva 30,000 acciones indirectamente a través del Timothy E. Bixby Family Trust y 277,300 opciones sin ejercer con vencimiento el 25 de septiembre de 2029.

La actividad representa menos del 0,02 % de las 67 millones de acciones en circulación de LMND y parece ser una diversificación rutinaria de cartera más que una señal sobre los fundamentos del negocio. Ningún otro insider realizó transacciones y no se utilizó dinero de la empresa.

Lemonade, Inc. (LMND) – 내부자 신고서 Form 4

최고재무책임자(CFO) Timothy E. Bixby는 완전히 취득된 직원 스톡옵션 7,000주를 행사가격 23.69달러에 행사한 후, 같은 7,000주를 Rule 10b5-1 계획에 따라 매도했습니다. 매도는 2025년 7월 18일(6,000주, 주당 42.50달러)과 7월 21일(1,000주, 주당 42.70달러)에 이루어졌으며, 총 매출은 약 30만 달러, 행사가격 총액은 약 17만 달러였습니다.

거래 후 Bixby 씨의 직접 보유 주식은 옵션 행사 전과 동일한 263,393주로 유지되고 있습니다. 또한 Timothy E. Bixby 가족 신탁을 통해 간접적으로 30,000주를 보유하고 있으며, 만기일이 2029년 9월 25일인 미행사 옵션 277,300주도 보유 중입니다.

이번 거래는 LMND의 발행 주식 6,700만 주 중 0.02% 미만에 해당하며, 사업 기초 체력에 대한 신호보다는 일상적인 포트폴리오 다각화로 보입니다. 다른 내부자는 거래하지 않았으며 회사 자금은 사용되지 않았습니다.

Lemonade, Inc. (LMND) – Déclaration d’initié Formulaire 4

Le directeur financier Timothy E. Bixby a exercé 7 000 options d’achat d’actions entièrement acquises au prix d’exercice de 23,69 $, puis a vendu ces mêmes 7 000 actions dans le cadre d’un plan Rule 10b5-1. Les ventes ont eu lieu les 18 juillet 2025 (6 000 actions à 42,50 $) et 21 juillet 2025 (1 000 actions à 42,70 $), générant un produit brut d’environ 0,30 million de dollars contre un coût d’exercice total d’environ 0,17 million de dollars.

Après ces opérations, la détention directe de M. Bixby reste de 263 393 actions ordinaires, inchangée par rapport au niveau avant l’exercice des options. Il détient également 30 000 actions indirectement via le Timothy E. Bixby Family Trust et 277 300 options non exercées expirant le 25 septembre 2029.

Cette activité représente moins de 0,02 % des 67 millions d’actions en circulation de LMND et semble correspondre à une diversification de portefeuille routinière plutôt qu’à un signal sur les fondamentaux de l’entreprise. Aucun autre initié n’a effectué de transaction et aucun fonds de la société n’a été engagé.

Lemonade, Inc. (LMND) – Insider-Meldung Form 4

Finanzvorstand Timothy E. Bixby hat 7.000 vollständig erworbene Mitarbeiteraktienoptionen zum Ausübungspreis von 23,69 USD ausgeübt und anschließend dieselben 7.000 Aktien im Rahmen eines Rule 10b5-1-Plans verkauft. Die Verkäufe erfolgten am 18. Juli 2025 (6.000 Aktien zu 42,50 USD) und am 21. Juli 2025 (1.000 Aktien zu 42,70 USD) und erzielten Bruttoerlöse von etwa 0,30 Millionen USD bei Gesamtkosten von rund 0,17 Millionen USD.

Nach den Transaktionen hält Herr Bixby weiterhin direkt 263.393 Stammaktien, unverändert gegenüber dem Bestand vor Ausübung der Optionen. Zudem besitzt er 30.000 Aktien indirekt über den Timothy E. Bixby Family Trust sowie 277.300 nicht ausgeübte Optionen mit Ablaufdatum 25. September 2029.

Die Transaktion entspricht weniger als 0,02 % der 67 Millionen ausstehenden LMND-Aktien und stellt eher eine routinemäßige Portfolio-Diversifikation als ein Signal für die Geschäftsentwicklung dar. Keine weiteren Insider haben Transaktionen getätigt, und es wurden keine Unternehmensmittel eingesetzt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR – Small, routine 10b5-1 sale; immaterial to valuation.

The CFO merely swapped 7,000 options for stock, then liquidated the shares at a 79% spread to strike, netting about $131 k after costs. His ownership percentage and voting power are unchanged, and the sale represents a de minimis slice of the float. Option exercises marginally lower his remaining option pool, but there is no new dilution to shareholders because the exercised shares were already reserved. Given LMND’s multi-billion-dollar market cap, the transaction has no forecast or cash-flow impact and should not affect the investment thesis.

TL;DR – Filing shows good compliance; no red flags.

The transaction was executed under a pre-arranged Rule 10b5-1 plan, signalling procedural rigor and reducing the likelihood of informational abuse. The Form 4 was filed within the two-business-day window, and explanatory footnotes clearly outline the trust relationship and option status. Insider’s direct stake remains sizeable (> $11 m at current prices), aligning interests with shareholders. There are no patterns of accelerated selling or unusual derivatives activity. Overall governance implications are neutral to slightly positive.

Lemonade, Inc. (LMND) – Comunicazione interna Form 4

Il CFO Timothy E. Bixby ha esercitato 7.000 opzioni azionarie dipendenti completamente maturate al prezzo di esercizio di 23,69 dollari, vendendo poi le stesse 7.000 azioni tramite un piano Rule 10b5-1. Le vendite sono avvenute il 18 luglio 2025 (6.000 azioni a 42,50 dollari) e il 21 luglio 2025 (1.000 azioni a 42,70 dollari), generando proventi lordi di circa 0,30 milioni di dollari contro un costo complessivo di esercizio di circa 0,17 milioni di dollari.

Dopo queste operazioni, la partecipazione diretta del sig. Bixby rimane di 263.393 azioni ordinarie, invariata rispetto al livello precedente all’esercizio delle opzioni. Detiene inoltre 30.000 azioni indirettamente tramite il Timothy E. Bixby Family Trust e 277.300 opzioni non esercitate con scadenza il 25 settembre 2029.

L’operazione rappresenta meno dello 0,02% delle 67 milioni di azioni in circolazione di LMND e sembra essere una normale diversificazione del portafoglio piuttosto che un segnale sui fondamentali aziendali. Nessun altro insider ha effettuato transazioni e non è stato coinvolto denaro aziendale.

Lemonade, Inc. (LMND) – Presentación interna Formulario 4

El CFO Timothy E. Bixby ejerció 7,000 opciones sobre acciones de empleados totalmente adquiridas a un precio de ejercicio de 23,69 dólares, para luego vender esas mismas 7,000 acciones bajo un plan Rule 10b5-1. Las ventas se realizaron el 18 de julio de 2025 (6,000 acciones a 42,50 dólares) y el 21 de julio de 2025 (1,000 acciones a 42,70 dólares), generando ingresos brutos de aproximadamente 0,30 millones de dólares frente a un costo total de ejercicio de alrededor de 0,17 millones de dólares.

Tras las transacciones, la participación directa del Sr. Bixby se mantiene en 263,393 acciones comunes, sin cambios respecto al nivel previo al ejercicio de las opciones. También conserva 30,000 acciones indirectamente a través del Timothy E. Bixby Family Trust y 277,300 opciones sin ejercer con vencimiento el 25 de septiembre de 2029.

La actividad representa menos del 0,02 % de las 67 millones de acciones en circulación de LMND y parece ser una diversificación rutinaria de cartera más que una señal sobre los fundamentos del negocio. Ningún otro insider realizó transacciones y no se utilizó dinero de la empresa.

Lemonade, Inc. (LMND) – 내부자 신고서 Form 4

최고재무책임자(CFO) Timothy E. Bixby는 완전히 취득된 직원 스톡옵션 7,000주를 행사가격 23.69달러에 행사한 후, 같은 7,000주를 Rule 10b5-1 계획에 따라 매도했습니다. 매도는 2025년 7월 18일(6,000주, 주당 42.50달러)과 7월 21일(1,000주, 주당 42.70달러)에 이루어졌으며, 총 매출은 약 30만 달러, 행사가격 총액은 약 17만 달러였습니다.

거래 후 Bixby 씨의 직접 보유 주식은 옵션 행사 전과 동일한 263,393주로 유지되고 있습니다. 또한 Timothy E. Bixby 가족 신탁을 통해 간접적으로 30,000주를 보유하고 있으며, 만기일이 2029년 9월 25일인 미행사 옵션 277,300주도 보유 중입니다.

이번 거래는 LMND의 발행 주식 6,700만 주 중 0.02% 미만에 해당하며, 사업 기초 체력에 대한 신호보다는 일상적인 포트폴리오 다각화로 보입니다. 다른 내부자는 거래하지 않았으며 회사 자금은 사용되지 않았습니다.

Lemonade, Inc. (LMND) – Déclaration d’initié Formulaire 4

Le directeur financier Timothy E. Bixby a exercé 7 000 options d’achat d’actions entièrement acquises au prix d’exercice de 23,69 $, puis a vendu ces mêmes 7 000 actions dans le cadre d’un plan Rule 10b5-1. Les ventes ont eu lieu les 18 juillet 2025 (6 000 actions à 42,50 $) et 21 juillet 2025 (1 000 actions à 42,70 $), générant un produit brut d’environ 0,30 million de dollars contre un coût d’exercice total d’environ 0,17 million de dollars.

Après ces opérations, la détention directe de M. Bixby reste de 263 393 actions ordinaires, inchangée par rapport au niveau avant l’exercice des options. Il détient également 30 000 actions indirectement via le Timothy E. Bixby Family Trust et 277 300 options non exercées expirant le 25 septembre 2029.

Cette activité représente moins de 0,02 % des 67 millions d’actions en circulation de LMND et semble correspondre à une diversification de portefeuille routinière plutôt qu’à un signal sur les fondamentaux de l’entreprise. Aucun autre initié n’a effectué de transaction et aucun fonds de la société n’a été engagé.

Lemonade, Inc. (LMND) – Insider-Meldung Form 4

Finanzvorstand Timothy E. Bixby hat 7.000 vollständig erworbene Mitarbeiteraktienoptionen zum Ausübungspreis von 23,69 USD ausgeübt und anschließend dieselben 7.000 Aktien im Rahmen eines Rule 10b5-1-Plans verkauft. Die Verkäufe erfolgten am 18. Juli 2025 (6.000 Aktien zu 42,50 USD) und am 21. Juli 2025 (1.000 Aktien zu 42,70 USD) und erzielten Bruttoerlöse von etwa 0,30 Millionen USD bei Gesamtkosten von rund 0,17 Millionen USD.

Nach den Transaktionen hält Herr Bixby weiterhin direkt 263.393 Stammaktien, unverändert gegenüber dem Bestand vor Ausübung der Optionen. Zudem besitzt er 30.000 Aktien indirekt über den Timothy E. Bixby Family Trust sowie 277.300 nicht ausgeübte Optionen mit Ablaufdatum 25. September 2029.

Die Transaktion entspricht weniger als 0,02 % der 67 Millionen ausstehenden LMND-Aktien und stellt eher eine routinemäßige Portfolio-Diversifikation als ein Signal für die Geschäftsentwicklung dar. Keine weiteren Insider haben Transaktionen getätigt, und es wurden keine Unternehmensmittel eingesetzt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Fyrwald J Erik

(Last) (First) (Middle)
LILLY CORPORATE CENTER

(Street)
INDIANAPOLIS IN 46285

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/21/2025 A 13.011(1) A $762.18 73,012.779 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
Remarks:
/s/ Jonathan Groff for J. Erik Fyrwald, pursuant to authorization on file 07/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Lemonade (LMND) shares did the CFO sell?

Timothy Bixby sold 7,000 common shares in two trades on 18 and 21 July 2025.

What was the average sale price for the insider transactions?

Shares were sold at $42.50 and $42.70, producing an average of roughly $42.53 per share.

Did the CFO’s overall ownership in LMND change after the Form 4 transactions?

No. Direct holdings remain 263,393 shares; 30,000 indirect trust shares are unchanged.

Were the sales executed under a Rule 10b5-1 trading plan?

Yes, the footnotes state the sales were made pursuant to a Rule 10b5-1 plan adopted 12 Dec 2024.

How many options does the CFO still hold after the exercises?

Mr. Bixby retains 277,300 unexercised stock options expiring 25 Sep 2029.
Lilly Eli & Co

NYSE:LLY

LLY Rankings

LLY Latest News

LLY Latest SEC Filings

LLY Stock Data

692.83B
945.64M
0.17%
83.56%
0.81%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
INDIANAPOLIS